Just on that point of ‘Approvals’ given you raised it …. Can you provide a list of the FDA approvals or EUA’s issued for all these cheaper alternative treatments for COVID-19 you have been telling us about for the last 18 months ?
………….
………….
………….
…………. didn’t think so ?
It does make me wonder why you criticise MSB for having no approval or EUA yet for its COVID-19 ARDS treatment but don’t feel the need to substantiate your cheaper alternatives by the same measuring stick - Approvals …. you would have to think it is going to be somewhat difficult for your suggested cheaper alternatives to actually treat people for COVID-19 without an FDA approval or an EAU issued …. and price of treatment aside; it seems like your touted cheaper alternatives are no further advanced than MSB is at present with Remestemcel-L - just sayin’
Watch this space I guess ?
$90 a share on COVID ARDS Authorization ?, page-38
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.40 |
Change
0.045(3.33%) |
Mkt cap ! $1.592B | |||
| Open | High | Low | Value | Volume |
| $1.35 | $1.42 | $1.33 | $3.802M | 2.753M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 23940 | $1.39 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.40 | 22571 | 2 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |